Immunogram is a clinical research platform allowing multimodal analysis to understand the tumor microenvironment.
It integrates Immunoscore® assays, innovative technologies such as Multiplex Spatial Tissue Analysis (Brightplex®) and molecular testing in order to improve prediction of the response to therapy and personalize treatment.
Immunogram is a customizable tool enabling to picture the relevant biomarkers and phenotypes and provide a 360° view on the tumor immune contexture.
It can include several of our assays:
All assays are amenable to clinical trial assays and companion diagnostics.
The Cancer Immune Atlas is a customized multimarker database in a given cancer type applying the Immunogram multimodal approach on a large number of patients’ samples.
This unique compendium of biomarkers and phenotypes provides a statistically relevant insight into the immune contexture in order to guide drug development.
Immunogram to decipher PD1/L1 ICI resistance: a proof of concept in advanced Non-small cell lung cancer patients of the PIONeeR Project.
Combining multimodal biomarkers as an immunogram to guide immunotherapy use: A Proof of Concept
HalioDx Biopharma Services